The Company was formed in March, 2004, when a wholly owned subsidiary of US Oncology Holdings Inc. agreed to merge with and into US Oncology, with US Oncology continuing as the surviving corporation and a wholly owned subsidiary of Holdings (the “Merger”). On August 20, 2004, the Merger, valued at approximately $1.6 billion, was consummated. Currently, Holdings’ principal asset is 100% of the shares of common stock of US Oncology Inc. (“US Oncology”). Holdings conducts all of its business through US Oncology and its headquarters are located in The Woodlands, Texas.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Latest filings (excl ownership)
8-K
Termination of a Material Definitive Agreement
4 Feb 11
8-K
Termination of a Material Definitive Agreement
30 Dec 10
8-K
Regulation FD Disclosure
22 Dec 10
10-Q
2010 Q3
Quarterly report
5 Nov 10
8-K
Entry into a Material Definitive Agreement
3 Nov 10
8-K
Departure of Directors or Certain Officers
25 Aug 10
10-Q
2010 Q2
Quarterly report
11 Aug 10
8-K
US Oncology Reports Second Quarter 2010 Operating Results
11 Aug 10
8-K
US Oncology Reports First Quarter 2010 Operating Results
11 May 10
Latest ownership filings
No filings